H
Hayley Loblein
Publications - 3
Citations - 231
Hayley Loblein is an academic researcher. The author has contributed to research in topics: Immunogenicity & Serotype. The author has an hindex of 2, co-authored 2 publications receiving 201 citations.
Papers
More filters
Journal ArticleDOI
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
Lindsey R. Baden,Lindsey R. Baden,Lindsey R. Baden,Stephen R. Walsh,Stephen R. Walsh,Michael S. Seaman,Michael S. Seaman,Robert Tucker,Kathleen H. Krause,Alka Patel,Jennifer Johnson,Jennifer Johnson,Jane A. Kleinjan,Katherine E. Yanosick,James R. Perry,Elise Zablowsky,Peter Abbink,Lauren Peter,M. Justin Iampietro,Ann Cheung,Maria G. Pau,Mo Weijtens,Jaap Goudsmit,Edith Swann,Mark Wolff,Hayley Loblein,Raphael Dolin,Raphael Dolin,Raphael Dolin,Dan H. Barouch,Dan H. Barouch,Dan H. Barouch +31 more
TL;DR: This Ad26 vectored vaccine was generally safe and immunogenic at all doses tested and is a promising new vaccine vector for HIV-1.
Journal ArticleDOI
Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans
Lindsey R. Baden,Jinyan Liu,Hualin Li,Jennifer Johnson,Stephen R. Walsh,Jane A. Kleinjan,Brian A. Engelson,Lauren Peter,Peter Abbink,Danny A. Milner,Kevin L. Golden,Kyle L. Viani,Matthew D. Stachler,Benjamin J. Chen,Maria G. Pau,Mo Weijtens,Brittany R. Carey,Caroline A. Miller,Edith Swann,Mark Wolff,Hayley Loblein,Michael S. Seaman,Raphael Dolin,Dan H. Barouch +23 more
TL;DR: These data demonstrate that a single intramuscular administration of this Ad26-vectored HIV-1 Env vaccine elicited both systemic and mucosal immune responses in humans.
Journal ArticleDOI
Prevalence of neurodevelopmental disorders in a clinically referred sample of children with CHD
TL;DR: The results confirm that children and adolescents with CHD are at high risk for neurodevelopmental disorders and require ongoing monitoring, care, and support.